Author

Mia Malmenäs

Observed name: Malmenäs, Mia

Institution: ICON PLC (Ireland)

Observed institution: ICON PLC (Ireland)

ORCID: 0000-0002-2625-9198

Observed ORCID: 0000-0002-2625-9198

OpenAlex ID: A5015850818

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis

2022 · Afisi S. Ismaila, Katrin Haeussler, et al. · Advances in Therapy · 44

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

2022 · Afisi S. Ismaila, Katrin Haeussler, et al. · Advances in Therapy · 14

Vaccine preparation time, errors, satisfaction, and preference of prefilled syringes versus RSV vaccines requiring reconstitution: randomized, time and motion study

2024 · Darshan Mehta, Samantha Kimball-Carroll, et al. · Journal of Medical Economics · 9

Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians

2024 · Katrin Haeussler, Afisi S. Ismaila, et al. · Respiratory Research · 4

Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema

2025 · Maureen Watt, Rachel Goldgrub, et al. · Journal of Comparative Effectiveness Research · 1

A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”

2023 · Afisi S. Ismaila, Katrin Haeussler, et al. · Advances in Therapy

Works count: 9

Citation count: 72

H-index: 4

I10-index: 2